The Analysis of Remedium Capital Partners, LLC's Holdings & P&L


Currently, Remedium Capital Partners, LLC holds 6 types of securities in its portfolio with a total value $451.6M. In the most recent quarter, they have increased their positions in CBIO (+361.3K shares, valued at $6.5M), APGE (+3.1K shares, valued at $411.5K); decreased their positions in SYRE (-443.2K shares, valued at $39.3M), ORKA (-323.5K shares, valued at $30.8M); initiated new positions in CBIO (+361.3K shares, valued at $6.5M).


1M P&L
-26.6M-8.43%
3M P&L
-42.9M-12.94%
HY P&L
+30.1M+11.63%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology398.4M
88.2%
2N/A53.2M
11.8%

Top Industries by Stock Count

1Biotechnology5 stocks
83.3%
2N/A1 stocks
16.7%
Stock Holdings
ORKA
Oruka Therapeutics Inc
-17.12%
Shares1.6M
Event2026-06-30
Filed2026-08-07
SYRE
Spyre Therapeutics Inc
-23.23%
Shares1.5M
Event2026-06-30
Filed2026-08-07
APGE
Apogee Therapeutics Inc
0.53%
Shares586.7K
Event2026-06-30
Filed2026-08-07
DMRA
Damora Therapeutics Inc
0.00%
Shares2.0M
Event2026-06-30
Filed2026-08-07
JBIO
Jade Biosciences Inc
0.00%
Shares1.6M
Event2026-06-30
Filed2026-08-07
CBIO
Crescent Biopharma Inc
New
Shares361.3K
Event2026-06-30
Filed2026-08-07

Call Option Holdings
No call option holdings data available

Put Option Holdings
No put option holdings data available